Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: United Kingdom,Sweden,Netherlands,Czech Republic,Russian Federation,Greece,Germany,Italy,Spain,United States
nct
Update Il y a 5 ans
A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care
The purpose of this study is to determine whether patients with high-risk myelodysplastic syndromes (MDS) treated with azacitidine have improved survival compared to conventional care treatments. The study will also assess the effect of treatments on response, duration of response, and transformation to acute myeloid leukemia (AML). The study will continue for 12 months following last patient enrolled. See study AZA PH GL 2003 CL 001 E for information about the extension to this study.
Country
Australia
,
Bulgaria
,
Czech Republic
,
France
,
Germany
,
Greece
,
Hungary
,
Italy
,
Netherlands
,
Poland
,
Russian Federation
,
Spain
,
Sweden
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Closed trial
More information
1